Cargando…
Current Perspectives on HIV-1 Antiretroviral Drug Resistance
Current advancements in antiretroviral therapy (ART) have turned HIV-1 infection into a chronic and manageable disease. However, treatment is only effective until HIV-1 develops resistance against the administered drugs. The most recent antiretroviral drugs have become superior at delaying the evolu...
Autores principales: | Iyidogan, Pinar, Anderson, Karen S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213579/ https://www.ncbi.nlm.nih.gov/pubmed/25341668 http://dx.doi.org/10.3390/v6104095 |
Ejemplares similares
-
Drug-Resistant Tuberculosis and HIV Infection: Current Perspectives
por: Singh, Abhijeet, et al.
Publicado: (2020) -
Perspectives on the Barrier to Resistance for Dolutegravir + Lamivudine, a Two-Drug Antiretroviral Therapy for HIV-1 Infection
por: Boffito, Marta, et al.
Publicado: (2020) -
Future of Antiretroviral Drugs and Evolution of HIV-1 Drug Resistance
por: Charpentier, Charlotte, et al.
Publicado: (2023) -
HIV DNA Sequencing to Detect Archived Antiretroviral Drug Resistance
por: Geretti, Anna Maria, et al.
Publicado: (2022) -
HIV-1 Drug Resistance Genotyping in Resource Limited Settings: Current and Future Perspectives in Sequencing Technologies
por: Manyana, Sontaga, et al.
Publicado: (2021)